Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience.

"Declaration of competing interest MZ reports grants and personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Chiesi, personal fees from Astra Zeneca and personal fees from GSK outside the submitted work. FB reports personal fees and non-financial support from Novartis, personal fees and non-financial support from Chiesi, grants, personal fees and non-financial support from AstraZeneca, outside the submitted work.PH reports non-financial support from Avad, outside the submitted work. Other authors have no conflicts of interest to disclose."

"Funding Devices and consumables used for EtCO2measurements were provided by L3 Medical SARL, which was not involved in the current study."

"This longitudinal observational study was conducted in two ambulatory physiotherapy structures specialised in outpatient respiratory rehabilitation in Bordeaux area, France. The study protocol was registered under number F20210419101248 on Health Data Hub (www.heath-data-hub.fr) and conformity declaration was provided to the Commission Nationale Informatique et Libertés (CNIL; www.cnil.fr) under registration number 2221978v0. Written informed consent was obtained from all participants. Study protocol was conducted according to STROBE guidelines."